MALGORZATA MORDARSKA: Open Payments
NPI 1114692902 · PARADISE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 39 payments from 12 companies in 2025. Trend: 2023 $139 · 2024 $491 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $236 |
| KYOWA KIRIN, INC. | 3 | $77 |
| Dexcom, Inc. | 2 | $63 |
| Exact Sciences Corporation | 3 | $52 |
| Indivior Inc. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Amgen Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $24 |
Products named: QULIPTA, CRYSVITA, MAVYRET, Dexcom G6 Transmitter, SUBLOCADE, UBRELVY, REXULTI, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
